192323-61-8Relevant articles and documents
Halogenated sulfonamide derivatives
-
Page/Page column 10-11, (2010/11/28)
This invention is directed to halogenated sulfonamide derivatives which are ligands at the NPY Y5 receptor. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutic
Pyrimidine compounds
-
Page/Page column 122-124, (2008/06/13)
This invention relates to a method for treating inflammatory diseases or immune diseases, developmental or degenerative diseases, or tissue injuries. The method includes administering to a subject in need thereof an effective amount of one or more compounds of formula (I). Each variable in this formula is defined in the specification.